Prescription drug · ANDA
Cefazolin NDC 0404-9835
Cefazolin sodium 225 mg/mL · Injection, Powder, For solution · Intramuscular, Intravenous · Henry Schein Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0404-9835-99 | 0040498359900404983599 | 1 VIAL in 1 BAG (0404-9835-99) / 2.2 mL in 1 VIALMarketed from Jan 9, 2022 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Cefazolin
- Generic name (nonproprietary)
- cefazolin
- Active ingredients
- Cefazolin sodium — 225 mg/mL
- Dosage form
- Injection, Powder, For solution
- Route
- Intramuscular, Intravenous
- Labeler
- Henry Schein Inc.NDC labeler code 0404
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 065047
- Marketing start
- Marketing end
- Other FDA classes
- Cephalosporins (Chemical structure)
- Identifiers
- Product ID 0404-9835_080d0356-a051-4375-b201-887475787a70SPL ID 080d0356-a051-4375-b201-887475787a70
- Pharmacologic class
- Cephalosporin Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400404983599followed by a unit qualifier and the quantityPackage 00404-9835-99. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 0404-9835
- What is NDC 0404-9835?
- 0404-9835 is the product NDC for Cefazolin, Cefazolin sodium 225 mg/mL injection, powder, for solution, listed with the FDA by Henry Schein Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Cefazolin.
- What is the active ingredient?
- Cefazolin sodium.
- Who is the labeler?
- Henry Schein Inc., NDC labeler code 0404. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Cefazolin?
- 42 other product NDCs are listed under this name. See all Cefazolin NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Cefazolin products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Cefazolin | Cefazolin sodium 2 g/1 | Injection, Powder, For solutionIntravenous | Civica, Inc. | 72572-054 | 72572-0054-25 |
| Cefazolincefazolin sodium | Cefazolin sodium 3 g/150mL | Injection, SolutionIntravenous | Baxter Healthcare Corporation | 0338-0096 | 00338-0096-06 |
| Cefazolin | Cefazolin sodium 3 g/1 | Injection, Powder, For solutionIntravenous | WG Critical Care, LLC | 44567-845 | 44567-0845-25 |
| Cefazolin | Cefazolin sodium 3 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | Apotex Corp. | 60505-6266 | 60505-6266-05 |
| Cefazolin | Cefazolin sodium 2 g/1 | Injection, Powder, For solutionIntravenous | WG Critical Care, LLC | 44567-840 | 44567-0840-25 |
| Cefazolin | Cefazolin sodium 2 g/1 | Injection, Powder, For solutionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9139 | 00143-9139-25 |
| Cefazolin | Cefazolin sodium 3 g/1 | Injection, Powder, For solutionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9140 | 00143-9140-25 |
| Cefazolin | Cefazolin sodium 1 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | Apotex Corp. | 60505-6243 | 60505-6243-04 |
| Cefazolin | Cefazolin sodium 10 g/1 | Injection, Powder, For solutionIntravenous | Apotex Corp. | 60505-6244 | 60505-6244-04 |
| Cefazolin | Cefazolin sodium 2 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | Apotex Corp. | 60505-6231 | 60505-6231-05 |
Other NDCs under ANDA 065047
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Cefazolin | Cefazolin sodium 330 mg/mL | Injection, Powder, For solutionIntramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | 0143-9262 |
| Cefazolin | Cefazolin sodium 225 mg/mL | Injection, Powder, For solutionIntramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | 0143-9923 |
| Cefazolin | Cefazolin sodium 330 mg/mL | Injection, Powder, For solutionIntramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | 0143-9924 |
| Cefazolin | Cefazolin sodium 330 mg/mL | Injection, Powder, For solutionIntramuscular, Intravenous | Henry Schein, Inc. | 0404-9834 |
| Cefazolin | Cefazolin sodium 330 mg/mL | Injection, Powder, For solutionIntramuscular, Intravenous | A-S Medication Solutions | 50090-4256 |
| Cefazolin | Cefazolin sodium 330 mg/mL | Injection, Powder, For solutionIntramuscular, Intravenous | Medical Purchasing Solutions, LLC | 71872-7027 |
| Cefazolin | Cefazolin sodium 1 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | Civica, Inc. | 72572-055 |